Page last updated: 2024-11-05

trimebutine and Spasm

trimebutine has been researched along with Spasm in 1 studies

Trimebutine: Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.

Spasm: An involuntary contraction of a muscle or group of muscles. Spasms may involve SKELETAL MUSCLE or SMOOTH MUSCLE.

Research Excerpts

ExcerptRelevanceReference
" In the double-blind segment, 69 patients with chronic gastro-intestinal spasmodic conditions were allocated, according to a pre-set randomization table, to receive orally 3 daily doses of fenoverine (100 mg; 35 patients), trimebutine (150 mg; 14 patients) or placebo (20 patients) during an average of 8 days."5.06Fenoverine: a two-step, double-blind and open clinical assessments of its smooth muscle synchronizing effects. ( Bader, F, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bader, F1

Trials

1 trial available for trimebutine and Spasm

ArticleYear
Fenoverine: a two-step, double-blind and open clinical assessments of its smooth muscle synchronizing effects.
    Pharmatherapeutica, 1986, Volume: 4, Issue:7

    Topics: Administration, Oral; Adult; Aged; Benzoates; Biliary Dyskinesia; Clinical Trials as Topic; Double-B

1986